Table 3. Independent predictors for non-target lesion revascularization.

Variable	Univariate analysis			Multivariate analysis
	HR	95% CI	p-value	HR	95% CI	p-value
Age	0.988	0.956–1.022	0.487	0.985	0.947–1.023	0.432
Male	0.880	0.450–1.722	0.710	1.240	0.550–2.798	0.604
Diabetes	1.830	0.947–3.536	0.072	1.618	0.796–3.286	0.184
Hypertension	1.284	0.630–2.617	0.492
Dyslipidemia	0.765	0.392–1.494	0.433
Current smoker	1.496	0.735–3.048	0.267
CKD	8.451	2.497–28.606	0.001	8.730	2.175–35.036	0.002
History of MI	3.210	0.756–13.632	0.114
DCB angioplasty after OCT	1.317	0.615–2.823	0.478
First-generation DES	0.986	0.489–1.991	0.970
Homogeneous neointima	0.604	0.310–1.177	0.139
Heterogeneous neointima	2.024	1.025–4.000	0.042	2.237	1.023–4.890	0.044
Layered neointima	0.852	0.349–2.082	0.726
ACEi or ARB	0.891	0.416–1.907	0.766
Beta blocker	0.538	0.269–1.078	0.080	0.901	0.387–2.096	0.809
Statin	1.004	0.303–3.325	0.995

ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor antagonist; CKD, chronic kidney disease, CI, confidence interval; DCB, drug-coated balloon; DES, drug-eluting stent; MI, myocardial infarction; OCT, optical coherence tomography; HR, hazard ratio